Effect of Hemovag on herniorhaphy outcome

Revision of using Hemovac in Lichtenstein herniorhaphy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138902082220N2

Enrollment

Registered

2010-05-16

Start date

2008-03-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ingoinal hernioraphy. Inguinal hernia

Interventions

Intervention 1: hernioraphy without Hemovak. Intervention 2: hernioraphy with Hemovak.

Treatment - Surgery

hernioraphy without Hemovak

hernioraphy with Hemovak

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: having hernia, admission in surgery ward, suitable for this method. Exclusion criteria: disagreement of cooperation, coagulopathy, smoking, diabetes mellitus, addiction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Accepted surgical wound complications. Timepoint: few days after surgery. Method of measurement: physical examination.	—

Secondary

Measure	Time frame
Late complications. Timepoint: one month after surgery. Method of measurement: physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Mozafar

Shahid Beheshti University of Medical Sciences

mohamad_mozafar@yahoo.com+98 21 2271 1144

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026